Tuesday, December 10, 2024

Trachoma in Pakistan – WHO Validates Elimination Achievement

In a monumental achievement for public health, the World Health Organization (WHO) has officially validated the elimination of trachoma in Pakistan as a public health issue. Trachoma, caused by the infection of the Chlamydia trachomatis bacterium, can lead to irreversible blindness if left untreated.

With this validation, Pakistan has become the 19th country worldwide to achieve this historic milestone. This success underscores the government of Pakistan’s strong political commitment to public health and highlights the invaluable support provided by WHO, as well as the incredible contributions of health professionals, civil society, and partners like Sightsavers, Christian Blind Mission, and the Fred Hollows Foundation. This achievement is significant in the global fight against preventable diseases and their elimination.

In 1997, Pakistan was the first country certified free from the transmission of dracunculiasis (Guinea-worm disease). The elimination of trachoma in Pakistan adds to this legacy and signifies that this is not the end, but a precursor to more significant public health milestones.

PM’s Commitment to Eradicating Other Diseases

At a recent event celebrating this achievement, Prime Minister Shehbaz Sharif pledged to eradicate diseases like polio and hepatitis following the successful elimination of trachoma. “Today marks a pivotal moment in our journey towards a healthier Pakistan.

Together with our partners, we not only celebrate this achievement but reaffirm our unwavering commitment to effectively control and eliminate diseases that impede our socioeconomic development by ensuring quality healthcare is within reach for everyone in Pakistan,” the Prime Minister stated.

During the ceremony, WHO Head of Mission in Pakistan, Dr. Luo Dapeng, presented a trachoma-free Pakistan certificate to the Prime Minister. This certificate symbolizes the dedication of the health ministry and various stakeholders in the fight against this disease.

“As we have made Pakistan a trachoma-free country, we are also committed to eradicating polio and hepatitis as well,” the Prime Minister added.

Dr. Tedros Ghebreyesus, WHO Director-General, stated, “The elimination of trachoma in Pakistan is a monumental achievement for the country and for the global fight against the disease.”

WHO’s Regional Director for the Eastern Mediterranean, Dr. Hanan Balkhy, emphasized the importance of this achievement, saying, “Congratulations to Pakistan on the elimination of trachoma! Now Pakistan has eliminated two neglected tropical diseases, demonstrating the country’s dedication to public health and serving as an inspiration to all.”

“This is a remarkable achievement that will save thousands of people from preventable visual impairment or blindness,” remarked WHO Representative in Pakistan, Dr. Luo Dapeng.

Pakistan’s success illustrates the effectiveness of the WHO-recommended SAFE strategy for eliminating trachoma, which includes surgical intervention for trichiasis, antibiotics to clear infection, and initiatives focused on facial cleanliness and environmental improvements to reduce transmission.

What’s Trachoma?

Trachoma in Pakistan - WHO Validates Elimination Achievement
Eye Infection

Trachoma is a chronic infectious disease caused by the bacterium Chlamydia trachomatis. It primarily affects the eyes and is the leading infectious cause of blindness worldwide. The disease is prevalent in areas with limited access to clean water, sanitation, and healthcare, making it a significant public health concern in many developing countries.

Trachoma is characterized by recurrent episodes of conjunctivitis (inflammation of the conjunctiva), which can lead to scarring of the eyelids and cornea, ultimately resulting in visual impairment or blindness if left untreated.

Types and Symptoms of Trachoma

Trachoma progresses through several stages, each with distinct clinical features. The types include:

1. Follicular Trachoma (TF)

  • Description: This is the early stage of trachoma, where small, raised bumps called follicles develop on the inner surface of the eyelid and the conjunctiva.
  • Symptoms: Patients may experience mild irritation and redness of the eye. It is often asymptomatic, making early detection challenging.
  • Diagnosis: Diagnosis is typically made through a clinical examination by a healthcare professional who observes the presence of follicles.

2. Papillary Trachoma (TI)

  • Description: In this intermediate stage, the conjunctiva becomes more inflamed and shows papillary changes. The follicles may become more prominent, and the eyelid may begin to thicken.
  • Symptoms: Increased discomfort, redness, and sensitivity to light. Patients might also experience tearing and discharge from the eye.
  • Diagnosis: Like follicular trachoma, papillary trachoma is diagnosed through an eye examination, with an emphasis on the appearance of papillary structures.

3. Cicatricial Trachoma (TS)

  • Description: This is the advanced stage of the disease, where chronic inflammation leads to scarring of the conjunctiva and eyelids. The scarring can cause the eyelashes to turn inward, a condition known as trichiasis.
  • Symptoms: Severe pain, discomfort, and visual impairment due to corneal damage from the inward-growing eyelashes. This stage can significantly impact quality of life.
  • Diagnosis: Diagnosis is based on the observation of scarred tissue and trichiasis during a comprehensive eye examination.

4. Trichiasis (TT)

  • Description: This stage occurs when the eyelashes grow inward and rub against the eyeball, leading to further irritation and damage to the cornea.
  • Symptoms: Extreme discomfort, potential for corneal ulcers, and risk of permanent blindness if untreated.
  • Diagnosis: Trichiasis is diagnosed when inward-turned eyelashes are observed during an eye examination.

Understanding the definition and types of trachoma is crucial for effective public health interventions aimed at eliminating this preventable cause of blindness. Early diagnosis and treatment can significantly reduce the incidence of advanced stages of the disease, improving health outcomes for affected populations.

Public health strategies, such as the WHO-recommended SAFE strategy (Surgery for trichiasis, Antibiotics for infection, Facial cleanliness, and Environmental improvement), are essential in managing and ultimately eliminating trachoma in endemic regions.

Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News